CFA
QDEL icon

Carroll Financial Associates’s QuidelOrtho QDEL Stock Holding History

Carroll Financial Associates’s Portfolio QDEL Stock Details QDEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-7
Closed – – 1866
2021
Q3 		$0 Buy
+7
New +$941 ﹤0.01% 1907

Other funds holding QDEL

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Carroll Financial Associates's QDEL Position: Q4 2021 in Review

Carroll Financial Associates sold out of QuidelOrtho (QDEL) in Q4 2021, closing a stake of 7 shares.

Carroll Financial Associates first reported a position in QDEL in Q3 2021 and held it in 1 quarter. The position peaked at $0 in Q3 2021. 361 funds tracked by Wall St. Rank hold QDEL as of Q4 2021.

  • Carroll Financial Associates reported no remaining QuidelOrtho position as of Q4 2021 after selling out during the quarter.
  • Carroll Financial Associates sold 7 QuidelOrtho shares in Q4 2021.
  • Carroll Financial Associates first reported a position in QuidelOrtho in Q3 2021 and held it in 1 quarter.
  • Carroll Financial Associates's QuidelOrtho position peaked at $0 in Q3 2021.
  • 361 funds tracked by Wall St. Rank held QuidelOrtho as of Q4 2021.

Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.